Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

10 Things You Must Know Before Planning a Trip to Bhutan

Published

on

Reading Time: 4 minutes

 

Situated in the east side of the enormous and gorgeous Himalayas, Bhutan is visualized as the land of monasteries, temples and of course, mesmerizing natural beauty and one of the most eye-catching wilderness. The country is unlike any other. There are unprecedented travel experiences, hiking, trekking, adventure, and spiritual that entice every visitor. PErtinently, Bhutan opened it’s borders for tourists after 1974, but more and more number of visitors are now visiting the country that contributes in making revenue for the country. The “High value, low impact” slogan which fits with its sustainable  methodology, has been in the tourism policy of Bhutan ever since that implies exclusivity and high production for the kingdom.

If you fancy a trip to this wonderful Himalayan country, here are a few things to consider before you start packing your bags.

 1)Best time to visit Bhutan?

The ideal time to tour Bhutan is during the spring season, i.e from March to May. It’s the time when flowers are blossoming, skies are clear and clearly visible Himalayan peaks. From June to August, the tourist season is all time low because of the incessant rains that significantly  restrict the tourist activities, such as trekking and sightseeing. But of course, travelling in this season would be least expensive than in peak seasons when the rush of visitors is quite high.

Since the country is also known for it’s buoyant and vigorous religious festivals, many people from all over the world like to witness the enthralling gala. These religious festivals and events are known as Tshechus, which means “10th day” and every temple and monastery hosts their Tshechu on the 10th of their selected month. These festivals are regarded with high respect and  people gather together for masked dances and receive blessings from their deities. These special events and festivals particularly attract visitors, creating a unique and remarkable aura. It also familiarises foreign people with the traditions,culture and history of Bhutan.

2) Choosing a tour operator

Travelling to Bhutan cannot be decided in a jiffy. The government of Bhutan requires tourists to plan their journey in advance and book their tour, artrange their visas, etc through government approved tour operators. It’s all pre-paid. The tourist fee per person per day is $200-250, including accommodation, food and travel within the country and an assigned travel guide. However citizens of India, Bangladesh and Maldives do not require a visa to visit Bhutan.

3) Food in Bhutan

The food in Bhutan is mostly quite spicy and almost every meal includes chillies. If you are not used to eating spicy food, you can ask for anything with no chillies. They will politely oblige. Rice and meat dishes are the staples. However veggies, momos and dumplings are also also available widely.

4) Dress Code

The traditional dress of Bhutan is a “gho” for men and “kira” for women. Gho is a long, knee-length robe like garment, wrapped around and held with a belt, while kira is an ankle-length dress accompanied by a jacket called “Tego”, with an inner layer known as a “Wonju”. The local people wear them on all occasions, in temples monasteries and Dzongs, etc. But visitors are not necessarily required to wear them. However while visiting their temples and other religious places, it’s important to ensure that you are covered. You must also remove your hat or cap if you are near their national flag, and remove your footwear as well when entering a holy place, such as a temple or a monastery.

5) Language

The language of Bhutan is Dzongkha. However, taxi drivers, shopkeepers, hotel and restaurant staff can speak and understand English quite well.

6) Photography

People of Bhutan are quite friendly. However they are shy too. If you want to take a picture of the local people there, seek permission first. However, avoid clicking pictures of any member from the Royal family. This could land you in trouble otherwise.

Photographing their temples and Dzongs is permitted but not where their deities are placed. Also keep in mind that wherever you require to take off your shoes, clicking pictures is prohibited. However you can always take help from you local tour guide.

7) Smoking is prohibited in Bhutan

Just like any other country, Bhutan also has it’s rules and regulations. It is imperative upon visitors to strictly adhere to them. The country has a stern and uncompromising policy for tobacco consumption. Smoking is totally banned at public places in Bhutan. However foreign tourists are allowed to carry a maximum of 200 cigarettes and you can find a hotel, restaurant or a bar to smoke. If you are caught smoking at a public place or their religious place, a high amount of fine can be imposed on you and you could even be sentenced jail.

8) Do not disrespect the tradition or the Royals

The Royals are considered the incarnation of their Gods and deities. So any indecent and rude remark towards the royals will not be appreciated. Make sure you do not mock them.

9) ATMs in Bhutan

ATMs are easily available in most parts of Bhutan. However the transaction charges might be variable. Foreign currency can be exchanged for the local currency when you land in Bhutan.

10) Get a local SIM card

There is no guarantee that your SIM card would work in Bhutan, as there is a handful of mobile service providers in the country. However you can get a local SIM quite easily to stay connected. You will need your passport You tour guide would help you getting one.

After having read about the kingdom, you must be certainly be excited for a Bhutan tour. If you desire a smooth, cheerful and hassle free tour experience, you can always count on bookmytour.bt for a trip to cherish, as we offer a wide range of packages that suit you best.

This article is a contribution of Ram Narayan Mandal

 

About the Author:

Ram Narayan Mandal, is a content manager at the BookMyTour.

He basically used to write about the topic that helps people to understand better about Bhutan.

 

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending